Virbac SA (EPA:VIRP)
France
· Delayed Price · Currency is EUR 305.40
+2.05 (0.68%)
Apr 24, 2025, 12:27 PM CET
Virbac Revenue
In the year 2024, Virbac had annual revenue of 1.40B EUR with 12.07% growth. Virbac had revenue of 694.45M in the half year ending December 31, 2024, with 15.78% growth.
Revenue
1.40B
Revenue Growth
+12.07%
P/S Ratio
1.82
Revenue / Employee
248.64K
Employees
5,620
Market Cap
2.54B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.40B | 150.48M | 12.07% |
| Dec 31, 2023 | 1.25B | 30.71M | 2.53% |
| Dec 31, 2022 | 1.22B | 152.22M | 14.31% |
| Dec 31, 2021 | 1.06B | 129.77M | 13.89% |
| Dec 31, 2020 | 934.20M | -4.14M | -0.44% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EssilorLuxottica Société anonyme | 26.51B |
| Sanofi | 44.29B |
| Sartorius Stedim Biotech | 2.86B |
| bioMérieux | 3.98B |
| Eurofins Scientific SE | 6.95B |
| Ipsen | 3.57B |
| emeis Société anonyme | 5.64B |
| Clariane SE | 5.28B |
Virbac News
- 8 days ago - Virbac: In the first quarter of 2025, revenue recorded solid growth of +4.9% at constant exchange rates and scope - GlobeNewsWire
- 9 days ago - Pet Dental Health Market Forecast Report 2025-2030, with Petdentist, Virbac, Animal Dental Clinic, iM3, The Happy Jack Co., Pet Kare Clinic, Felican Pet Hospital, Ruddington Vets, Pets'n'Vets and more - GlobeNewsWire
- 5 weeks ago - Full Year 2024 Virbac SA Earnings Presentation Transcript - GuruFocus
- 5 weeks ago - Virbac SA (VRBCF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Virbac: Public Release of the Year-End Consolidated Accounts at 31 December 2024 - GlobeNewsWire
- 5 weeks ago - Virbac: 2024 Annual results - GlobeNewsWire
- 2 months ago - India's Animal Healthcare Industry on a High-Growth Trajectory, Projected to Reach USD 2.0 Billion by 2034| Exclusive Report by Transparency Market Research Inc. - Benzinga
- 3 months ago - Virbac: Strong annual revenue growth of +13.6% supported by dynamic organic growth (+7.5%) and the strategic contribution of our acquisitions (+6.1%) - GlobeNewsWire